RNS Number:1528BVirotec International Ld23 July 200422 July...

RNS Number:1528B
Virotec International Ld
23 July 2004


22 July 2004


Virotec Announces Official Launch of its HydroDec Technology


The Directors of Virotec International Ltd (ASX/ AIM: VTI), are pleased to
announce that the official launch of Virotec's new and exclusive HydroDecTM
Technology will take place at Australia's Parliament House on 1 September 2004.



HydroDecTM technology, developed over 12 years by the Australian CSIRO
(Commonwealth Scientific & Industrial Research Organisation) in collaboration
with Transgrid is being commercialised by Virotec under an exclusive licence
agreement and the Directors believe it has great potential in the recycling of
transformer oils. Its patented re-refining technology is able to efficiently
re-refine used transformer oil, including PCB contaminated oils, to produce a
new oil at a similar quality as traditional hydrotreatment refining processes.


HydroDecTM technology has also been successfully applied to the destruction of a
wide range of chlorinated hydrocarbons (PCB, DDT, PCP, HCB and dioxins) and a
significant benefit of this process is that, unlike incineration, it makes the
formation of dioxins totally impossible.


Executive Chairman and CEO, Brian Sheeran explains "The Technology has no
harmful emissions. To date we have committed approximately $1 Million to this
project over 18 months and we are pleased to announce that a small HydroDecTM
plant is now fully operational in Young, NSW Australia, processing transformer
oil from Australian power utilities. To date the Company has secured orders with
a value of approximately AUD$580,000."



Virotec's exclusive global licence to commercialise HydroDecTM Technology has a
term of 15 years or the life of the Intellectual Property, whichever is longer.
In Australia, Virotec has entered into a Strategic partnership with Oil
Treatment Services Pty Ltd for the purpose of establishing and operating
HydroDecTM technology.



Brian Sheeran expands "This is not Virotec's core business but we believe it is
an exceptional opportunity that will definitely benefit Virotec shareholders.
Virotec plans to expand the HydroDecTM business, domestically and
internationally, and accordingly we are currently examining options on how we
can maximise returns to Virotec shareholders whilst not interfering with our
core business of marketing and implementing BauxsolTM Technology".


This information is provided by RNS
The company news service from the London Stock Exchange
END